메뉴 건너뛰기
Journal of Virology
Volumn 88, Issue 4, 2014, Pages 2000-2010
Protection provided by a herpes simplex virus 2 (HSV-2) glycoprotein C and D subunit antigen vaccine against genital HSV-2 infection in HSV-1-seropositive guinea pigs
Author keywords

[No Author keywords available]
Indexed keywords

ANALYSIS OF VARIANCE; ANIMALS; ANTIBODIES, NEUTRALIZING; BACULOVIRIDAE; CHO CELLS; CRICETINAE; CRICETULUS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GUINEA PIGS; HERPES GENITALIS; HERPESVIRUS 1, HUMAN; INJECTIONS, INTRAMUSCULAR; LIPID A; PICHIA; REAL-TIME POLYMERASE CHAIN REACTION; VIRAL ENVELOPE PROTEINS; VIRAL VACCINES;
EID: 84893506000     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.03163-13     Document Type: Article
Times cited : (36)
References (58)
  • 1
    • 37349036293 scopus 로고    scopus 로고
    • Genital herpes
    • Gupta R, Warren T, Wald A. 2007. Genital herpes. Lancet 370:2127-2137. http://dx.doi.org/10.1016/S0140-6736(07)61908-4.
    • (2007) Lancet , vol.370 , pp. 2127-2137
    • Gupta, R.1    Warren, T.2    Wald, A.3
  • 3
    • 54249103516 scopus 로고    scopus 로고
    • An estimate of the global prevalence and incidence of herpes simplex virus type 2 infection
    • Looker KJ, Garnett GP, Schmid GP. 2008. An estimate of the global prevalence and incidence of herpes simplex virus type 2 infection. Bull. World Health Organ. 86:805-812. http://dx.doi.org/10.2471/BLT.07.046128.
    • (2008) Bull. World Health Organ. , vol.86 , pp. 805-812
    • Looker, K.J.1    Garnett, G.P.2    Schmid, G.P.3
  • 4
    • 0020578052 scopus 로고
    • Genital herpes simplex virus infections: clinical manifestations, course, and complications
    • Corey L, Adams HG, Brown ZA, Holmes KK. 1983. Genital herpes simplex virus infections: clinical manifestations, course, and complications. Ann. Intern. Med. 98:958-972. http://dx.doi.org/10.7326/0003-4819-98-6-958.
    • (1983) Ann. Intern. Med. , vol.98 , pp. 958-972
    • Corey, L.1    Adams, H.G.2    Brown, Z.A.3    Holmes, K.K.4
  • 6
    • 79953848750 scopus 로고    scopus 로고
    • Genital shedding of herpes simplex virus among symptomatic and asymptomatic persons with HSV-2 infection
    • Tronstein E, Johnston C, Huang ML, Selke S, Magaret A, Warren T, Corey L, Wald A. 2011. Genital shedding of herpes simplex virus among symptomatic and asymptomatic persons with HSV-2 infection. JAMA 305:1441-1449. http://dx.doi.org/10.1001/jama.2011.420.
    • (2011) JAMA , vol.305 , pp. 1441-1449
    • Tronstein, E.1    Johnston, C.2    Huang, M.L.3    Selke, S.4    Magaret, A.5    Warren, T.6    Corey, L.7    Wald, A.8
  • 10
    • 29144444035 scopus 로고    scopus 로고
    • Herpes simplex virus 2 infection increases HIV acquisition in men and women: systematic review and meta-analysis of longitudinal studies
    • Freeman EE, Weiss HA, Glynn JR, Cross PL, Whitworth JA, Hayes RJ. 2006. Herpes simplex virus 2 infection increases HIV acquisition in men and women: systematic review and meta-analysis of longitudinal studies. AIDS 20:73-83. http://dx.doi.org/10.1097/01.aids.0000198081.09337.a7.
    • (2006) AIDS , vol.20 , pp. 73-83
    • Freeman, E.E.1    Weiss, H.A.2    Glynn, J.R.3    Cross, P.L.4    Whitworth, J.A.5    Hayes, R.J.6
  • 13
    • 0036137322 scopus 로고    scopus 로고
    • Risk of human immunodeficiency virus infection in herpes simplex virus type 2-seropositive persons: a meta-analysis
    • Wald A, Link K. 2002. Risk of human immunodeficiency virus infection in herpes simplex virus type 2-seropositive persons: a meta-analysis. J. Infect. Dis. 185:45-52. http://dx.doi.org/10.1086/338231.
    • (2002) J. Infect. Dis. , vol.185 , pp. 45-52
    • Wald, A.1    Link, K.2
  • 16
    • 0032824217 scopus 로고    scopus 로고
    • A temporal analysis of acyclovir inhibition of induced herpes simplex virus type 1 in vivo reactivation in the mouse trigeminal ganglia
    • Sawtell NM, Bernstein DI, Stanberry LR. 1999. A temporal analysis of acyclovir inhibition of induced herpes simplex virus type 1 in vivo reactivation in the mouse trigeminal ganglia. J. Infect. Dis. 180:821-823. http://dx.doi.org/10.1086/314958.
    • (1999) J. Infect. Dis. , vol.180 , pp. 821-823
    • Sawtell, N.M.1    Bernstein, D.I.2    Stanberry, L.R.3
  • 17
    • 0035887952 scopus 로고    scopus 로고
    • Early intervention with high-dose acyclovir treatment during primary herpes simplex virus infection reduces latency and subsequent reactivation in the nervous system in vivo
    • Sawtell NM, Thompson RL, Stanberry LR, Bernstein DI. 2001. Early intervention with high-dose acyclovir treatment during primary herpes simplex virus infection reduces latency and subsequent reactivation in the nervous system in vivo. J. Infect. Dis. 184:964-971. http://dx.doi.org/10.1086/323551.
    • (2001) J. Infect. Dis. , vol.184 , pp. 964-971
    • Sawtell, N.M.1    Thompson, R.L.2    Stanberry, L.R.3    Bernstein, D.I.4
  • 20
    • 70350569985 scopus 로고    scopus 로고
    • Immunization with HSV-1 glycoprotein C prevents immune evasion from complement and enhances the efficacy of an HSV-1 glycoprotein D subunit vaccine
    • Awasthi S, Lubinski JM, Friedman HM. 2009. Immunization with HSV-1 glycoprotein C prevents immune evasion from complement and enhances the efficacy of an HSV-1 glycoprotein D subunit vaccine. Vaccine 27:6845-6853. http://dx.doi.org/10.1016/j.vaccine.2009.09.017.
    • (2009) Vaccine , vol.27 , pp. 6845-6853
    • Awasthi, S.1    Lubinski, J.M.2    Friedman, H.M.3
  • 21
    • 80054987694 scopus 로고    scopus 로고
    • Immunization with a vaccine combining herpes simplex virus 2 (HSV-2) glycoprotein C (gC) and gD subunits improves the protection of dorsal root ganglia in mice and reduces the frequency of recurrent vaginal shedding of HSV-2 DNA in guinea pigs compared to immunization with gD alone
    • Awasthi S, Lubinski JM, Shaw CE, Barrett SM, Cai M, Wang F, Betts M, Kingsley S, Distefano DJ, Balliet JW, Flynn JA, Casimiro DR, Bryan JT, Friedman HM. 2011. Immunization with a vaccine combining herpes simplex virus 2 (HSV-2) glycoprotein C (gC) and gD subunits improves the protection of dorsal root ganglia in mice and reduces the frequency of recurrent vaginal shedding of HSV-2 DNA in guinea pigs compared to immunization with gD alone. J. Virol. 85:10472-10486. http://dx.doi.org/10.1128/JVI.00849-11.
    • (2011) J. Virol. , vol.85 , pp. 10472-10486
    • Awasthi, S.1    Lubinski, J.M.2    Shaw, C.E.3    Barrett, S.M.4    Cai, M.5    Wang, F.6    Betts, M.7    Kingsley, S.8    Distefano, D.J.9    Balliet, J.W.10    Flynn, J.A.11    Casimiro, D.R.12    Bryan, J.T.13    Friedman, H.M.14
  • 22
    • 5444259851 scopus 로고    scopus 로고
    • The complement system in regulation of adaptive immunity
    • Carroll MC. 2004. The complement system in regulation of adaptive immunity. Nat. Immunol. 5:981-986. http://dx.doi.org/10.1038/ni1113.
    • (2004) Nat. Immunol. , vol.5 , pp. 981-986
    • Carroll, M.C.1
  • 23
    • 0036104834 scopus 로고    scopus 로고
    • Complement component C3 promotes T-cell priming and lung migration to control acute influenza virus infection
    • Kopf M, Abel B, Gallimore A, Carroll M, Bachmann MF. 2002. Complement component C3 promotes T-cell priming and lung migration to control acute influenza virus infection. Nat. Med. 8:373-378. http://dx.doi.org/10.1038/nm0402-373.
    • (2002) Nat. Med. , vol.8 , pp. 373-378
    • Kopf, M.1    Abel, B.2    Gallimore, A.3    Carroll, M.4    Bachmann, M.F.5
  • 24
    • 49749103028 scopus 로고    scopus 로고
    • Complement-dependent enhancement of CD8+ T cell immunity to lymphocytic choriomeningitis virus infection in decay-accelerating factor-deficient mice
    • Fang C, Miwa T, Shen H, Song WC. 2007. Complement-dependent enhancement of CD8+ T cell immunity to lymphocytic choriomeningitis virus infection in decay-accelerating factor-deficient mice. J. Immunol.179:3178-3186.
    • (2007) J. Immunol. , vol.179 , pp. 3178-3186
    • Fang, C.1    Miwa, T.2    Shen, H.3    Song, W.C.4
  • 25
    • 40249116606 scopus 로고    scopus 로고
    • Locally produced complement fragments C5a and C3a provide both costimulatory and survival signals to naive CD4+ T cells
    • Strainic MG, Liu J, Huang D, An F, Lalli PN, Muqim N, Shapiro VS, Dubyak GR, Heeger PS, Medof ME. 2008. Locally produced complement fragments C5a and C3a provide both costimulatory and survival signals to naive CD4+ T cells. Immunity 28:425-435. http://dx.doi.org/10.1016/j.immuni.2008.02.001.
    • (2008) Immunity , vol.28 , pp. 425-435
    • Strainic, M.G.1    Liu, J.2    Huang, D.3    An, F.4    Lalli, P.N.5    Muqim, N.6    Shapiro, V.S.7    Dubyak, G.R.8    Heeger, P.S.9    Medof, M.E.10
  • 29
    • 0028100351 scopus 로고
    • The interaction of glycoprotein C of herpes simplex virus types 1 and 2 with the alternative complement pathway
    • Hung SL, Peng C, Kostavasili I, Friedman HM, Lambris JD, Eisenberg RJ, Cohen GH. 1994. The interaction of glycoprotein C of herpes simplex virus types 1 and 2 with the alternative complement pathway. Virology 203:299-312. http://dx.doi.org/10.1006/viro.1994.1488.
    • (1994) Virology , vol.203 , pp. 299-312
    • Hung, S.L.1    Peng, C.2    Kostavasili, I.3    Friedman, H.M.4    Lambris, J.D.5    Eisenberg, R.J.6    Cohen, G.H.7
  • 31
    • 0036057519 scopus 로고    scopus 로고
    • Kinetic analysis of glycoproteinCof herpes simplex virus types 1 and 2 binding to heparin, heparan sulfate, and complement component C3b
    • Rux AH, Lou H, Lambris JD, Friedman HM, Eisenberg RJ, Cohen GH. 2002. Kinetic analysis of glycoproteinCof herpes simplex virus types 1 and 2 binding to heparin, heparan sulfate, and complement component C3b. Virology 294:324-332. http://dx.doi.org/10.1006/viro.2001.1326.
    • (2002) Virology , vol.294 , pp. 324-332
    • Rux, A.H.1    Lou, H.2    Lambris, J.D.3    Friedman, H.M.4    Eisenberg, R.J.5    Cohen, G.H.6
  • 32
    • 47049112481 scopus 로고    scopus 로고
    • Blocking antibody access to neutralizing domains on glycoproteins involved in entry as a novel mechanism of immune evasion by herpes simplex virus type 1 glycoproteinsCand E
    • Hook LM, Huang J, Jiang M, Hodinka R, Friedman HM. 2008. Blocking antibody access to neutralizing domains on glycoproteins involved in entry as a novel mechanism of immune evasion by herpes simplex virus type 1 glycoproteinsCand E. J. Virol. 82:6935-6941. http://dx.doi.org/10.1128/JVI.02599-07.
    • (2008) J. Virol. , vol.82 , pp. 6935-6941
    • Hook, L.M.1    Huang, J.2    Jiang, M.3    Hodinka, R.4    Friedman, H.M.5
  • 33
    • 0242661046 scopus 로고    scopus 로고
    • Blocking immune evasion as a novel approach for prevention and treatment of herpes simplex virus infection
    • Judson KA, Lubinski JM, Jiang M, Chang Y, Eisenberg RJ, Cohen GH, Friedman HM. 2003. Blocking immune evasion as a novel approach for prevention and treatment of herpes simplex virus infection. J. Virol. 77: 12639-12645. http://dx.doi.org/10.1128/JVI.77.23.12639-12645.2003.
    • (2003) J. Virol. , vol.77 , pp. 12639-12645
    • Judson, K.A.1    Lubinski, J.M.2    Jiang, M.3    Chang, Y.4    Eisenberg, R.J.5    Cohen, G.H.6    Friedman, H.M.7
  • 34
    • 0037108418 scopus 로고    scopus 로고
    • Age-specific prevalence of infection with herpes simplex virus types 2 and 1: a global review
    • Smith JS, Robinson NJ. 2002. Age-specific prevalence of infection with herpes simplex virus types 2 and 1: a global review. J. Infect. Dis. 186:S3-S28. http://dx.doi.org/10.1086/343739.
    • (2002) J. Infect. Dis. , vol.186
    • Smith, J.S.1    Robinson, N.J.2
  • 37
    • 33646744394 scopus 로고    scopus 로고
    • Mucosal administration of CpG oligodeoxynucleotide elicits strong CC and CXC chemokine responses in the vagina and serves as a potent Th1-tilting adjuvant for recombinant gD2 protein vaccination against genital herpes
    • Tengvall S, Lundqvist A, Eisenberg RJ, Cohen GH, Harandi AM. 2006. Mucosal administration of CpG oligodeoxynucleotide elicits strong CC and CXC chemokine responses in the vagina and serves as a potent Th1-tilting adjuvant for recombinant gD2 protein vaccination against genital herpes. J. Virol. 80:5283-5291. http://dx.doi.org/10.1128/JVI.02013-05.
    • (2006) J. Virol. , vol.80 , pp. 5283-5291
    • Tengvall, S.1    Lundqvist, A.2    Eisenberg, R.J.3    Cohen, G.H.4    Harandi, A.M.5
  • 39
    • 0027954404 scopus 로고
    • High-level expression and purification of secreted forms of herpes simplex virus type 1 glycoprotein gD synthesized by baculovirus-infected insect cells
    • Sisk WP, Bradley JD, Leipold RJ, Stoltzfus AM, Ponce de Leon M, Hilf M, Peng C, Cohen GH, Eisenberg RJ. 1994. High-level expression and purification of secreted forms of herpes simplex virus type 1 glycoprotein gD synthesized by baculovirus-infected insect cells. J. Virol. 68:766-775.
    • (1994) J. Virol. , vol.68 , pp. 766-775
    • Sisk, W.P.1    Bradley, J.D.2    Leipold, R.J.3    Stoltzfus, A.M.4    Ponce de Leon, M.5    Hilf, M.6    Peng, C.7    Cohen, G.H.8    Eisenberg, R.J.9
  • 40
    • 73649091461 scopus 로고    scopus 로고
    • GlycoFi's technology to control the glycosylation of recombinant therapeutic proteins
    • Beck A, Cochet O, Wurch T. 2010. GlycoFi's technology to control the glycosylation of recombinant therapeutic proteins. Expert Opin. Drug Discov. 5:95-111. http://dx.doi.org/10.1517/17460440903413504.
    • (2010) Expert Opin. Drug Discov. , vol.5 , pp. 95-111
    • Beck, A.1    Cochet, O.2    Wurch, T.3
  • 41
    • 13444262282 scopus 로고    scopus 로고
    • The humanization of N-glycosylation pathways in yeast
    • Wildt S, Gerngross TU. 2005. The humanization of N-glycosylation pathways in yeast. Nat. Rev. Microbiol. 3:119-128. http://dx.doi.org/10.1038/nrmicro1087.
    • (2005) Nat. Rev. Microbiol. , vol.3 , pp. 119-128
    • Wildt, S.1    Gerngross, T.U.2
  • 44
    • 0031879861 scopus 로고    scopus 로고
    • Increasing the secretory capacity of Saccharomyces cerevisiae for production of singlechain antibody fragments
    • Shusta EV, Raines RT, Pluckthun A, Wittrup KD. 1998. Increasing the secretory capacity of Saccharomyces cerevisiae for production of singlechain antibody fragments. Nat. Biotechnol. 16:773-777. http://dx.doi.org/10.1038/nbt0898-773.
    • (1998) Nat. Biotechnol. , vol.16 , pp. 773-777
    • Shusta, E.V.1    Raines, R.T.2    Pluckthun, A.3    Wittrup, K.D.4
  • 45
    • 70349348947 scopus 로고    scopus 로고
    • Protection from herpes simplex virus (HSV)-2 infection with replication-defective HSV-2 or glycoprotein D2 vaccines in HSV-1-seropositive and HSV-1-seronegative guinea pigs
    • Hoshino Y, Pesnicak L, Dowdell KC, Burbelo PD, Knipe DM, Straus SE, Cohen JI. 2009. Protection from herpes simplex virus (HSV)-2 infection with replication-defective HSV-2 or glycoprotein D2 vaccines in HSV-1-seropositive and HSV-1-seronegative guinea pigs. J. Infect. Dis. 200:1088-1095. http://dx.doi.org/10.1086/605645.
    • (2009) J. Infect. Dis. , vol.200 , pp. 1088-1095
    • Hoshino, Y.1    Pesnicak, L.2    Dowdell, K.C.3    Burbelo, P.D.4    Knipe, D.M.5    Straus, S.E.6    Cohen, J.I.7
  • 47
    • 0019966496 scopus 로고
    • Genital herpes in guinea pigs: pathogenesis of the primary infection and description of recurrent disease
    • Stanberry LR, Kern ER, Richards JT, Abbott TM, Overall JC, Jr. 1982. Genital herpes in guinea pigs: pathogenesis of the primary infection and description of recurrent disease. J. Infect. Dis. 146:397-404. http://dx.doi.org/10.1093/infdis/146.3.397.
    • (1982) J. Infect. Dis. , vol.146 , pp. 397-404
    • Stanberry, L.R.1    Kern, E.R.2    Richards, J.T.3    Abbott, T.M.4    Overall Jr., J.C.5
  • 49
    • 84862673527 scopus 로고    scopus 로고
    • Iscomatrix: a novel adjuvant for use in prophylactic and therapeutic vaccines against infectious diseases
    • Morelli AB, Becher D, Koernig S, Silva A, Drane D, Maraskovsky E. 2012. Iscomatrix: a novel adjuvant for use in prophylactic and therapeutic vaccines against infectious diseases. J. Med. Microbiol. 61:935-943. http://dx.doi.org/10.1099/jmm.0.040857-0.
    • (2012) J. Med. Microbiol. , vol.61 , pp. 935-943
    • Morelli, A.B.1    Becher, D.2    Koernig, S.3    Silva, A.4    Drane, D.5    Maraskovsky, E.6
  • 50
    • 0037442496 scopus 로고    scopus 로고
    • Herpes simplex virus (HSV) type 2 glycoprotein D subunit vaccines and protection against genital HSV-1 or HSV-2 disease in guinea pigs
    • Bourne N, Bravo FJ, Francotte M, Bernstein DI, Myers MG, Slaoui M, Stanberry LR. 2003. Herpes simplex virus (HSV) type 2 glycoprotein D subunit vaccines and protection against genital HSV-1 or HSV-2 disease in guinea pigs. J. Infect. Dis. 187:542-549. http://dx.doi.org/10.1086/374002.
    • (2003) J. Infect. Dis. , vol.187 , pp. 542-549
    • Bourne, N.1    Bravo, F.J.2    Francotte, M.3    Bernstein, D.I.4    Myers, M.G.5    Slaoui, M.6    Stanberry, L.R.7
  • 51
    • 33645768170 scopus 로고    scopus 로고
    • Herpes simplex virus type 1 and 2 glycoprotein C prevents complementmediated neutralization induced by natural immunoglobulin M antibody.J
    • Hook LM, Lubinski JM, Jiang M, Pangburn MK, Friedman HM. 2006. Herpes simplex virus type 1 and 2 glycoprotein C prevents complementmediated neutralization induced by natural immunoglobulin M antibody.J. Virol. 80:4038-4046. http://dx.doi.org/10.1128/JVI.80.8.4038-4046.2006.
    • (2006) Virol. , vol.80 , pp. 4038-4046
    • Hook, L.M.1    Lubinski, J.M.2    Jiang, M.3    Pangburn, M.K.4    Friedman, H.M.5
  • 52
    • 0033523873 scopus 로고    scopus 로고
    • A prospective study of new infections with herpes simplex virus type 1 and type 2. Chiron HSV Vaccine Study Group
    • Langenberg AG, Corey L, Ashley RL, Leong WP, Straus SE. 1999. A prospective study of new infections with herpes simplex virus type 1 and type 2. Chiron HSV Vaccine Study Group. N. Engl. J. Med. 341:1432-1438.
    • (1999) N. Engl. J. Med. , vol.341 , pp. 1432-1438
    • Langenberg, A.G.1    Corey, L.2    Ashley, R.L.3    Leong, W.P.4    Straus, S.E.5
  • 53
    • 0029135197 scopus 로고
    • Virologic characteristics of subclinical and symptomatic genital herpes infections
    • Wald A, Zeh J, Selke S, Ashley RL, Corey L. 1995. Virologic characteristics of subclinical and symptomatic genital herpes infections. N. Engl. J.Med. 333:770-775. http://dx.doi.org/10.1056/NEJM199509213331205.
    • (1995) N. Engl. J.Med. , vol.333 , pp. 770-775
    • Wald, A.1    Zeh, J.2    Selke, S.3    Ashley, R.L.4    Corey, L.5
  • 54
    • 33947424353 scopus 로고    scopus 로고
    • Virus-specific CD8+ T cells accumulate near sensory nerve endings in genital skin during subclinical HSV-2 reactivation
    • Zhu J, Koelle DM, Cao J, Vazquez J, Huang ML, Hladik F, Wald A, Corey L. 2007. Virus-specific CD8+ T cells accumulate near sensory nerve endings in genital skin during subclinical HSV-2 reactivation. J.Exp. Med. 204:595-603. http://dx.doi.org/10.1084/jem.20061792.
    • (2007) J.Exp. Med. , vol.204 , pp. 595-603
    • Zhu, J.1    Koelle, D.M.2    Cao, J.3    Vazquez, J.4    Huang, M.L.5    Hladik, F.6    Wald, A.7    Corey, L.8
  • 55
    • 53749095611 scopus 로고    scopus 로고
    • Noncytotoxic lytic granule-mediated CD8+ T cell inhibition of HSV-1 reactivation from neuronal latency
    • Knickelbein JE, Khanna KM, Yee MB, Baty CJ, Kinchington PR, Hendricks RL. 2008. Noncytotoxic lytic granule-mediated CD8+ T cell inhibition of HSV-1 reactivation from neuronal latency. Science 322:268-271. http://dx.doi.org/10.1126/science.1164164.
    • (2008) Science , vol.322 , pp. 268-271
    • Knickelbein, J.E.1    Khanna, K.M.2    Yee, M.B.3    Baty, C.J.4    Kinchington, P.R.5    Hendricks, R.L.6
  • 57
    • 84869082967 scopus 로고    scopus 로고
    • A vaccine strategy that protects against genital herpes by establishing local memory T cells
    • Shin H, Iwasaki A. 2012. A vaccine strategy that protects against genital herpes by establishing local memory T cells. Nature 491:463-467. http://dx.doi.org/10.1038/nature11522.
    • (2012) Nature , vol.491 , pp. 463-467
    • Shin, H.1    Iwasaki, A.2
  • 58
    • 33745137449 scopus 로고    scopus 로고
    • Genital HSV-1 infections
    • Wald A. 2006. Genital HSV-1 infections. Sex. Transm. Infect. 82:189-190. http://dx.doi.org/10.1136/sti.2006.019935.
    • (2006) Sex. Transm. Infect. , vol.82 , pp. 189-190
    • Wald, A.1

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.